Missouri Valley Cancer Consortium CCOP
密苏里河谷癌症联盟 CCOP
基本信息
- 批准号:6949084
- 负责人:
- 金额:$ 93.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-30 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:antineoplastic antibioticsantineoplasticsbehavioral /social science research tagbiliary tract neoplasmblood /lymphatic neoplasmbone neoplasmsbrain neoplasmsbreast neoplasmscancer complicationcancer information systemcancer preventioncancer registry /resourcecancer rehabilitation /careceramideschemopreventionclinical researchclinical trialscolony stimulating factorcommunity health servicescooperative studydata managementesophagus neoplasmestrogensfemale reproductive system neoplasmgastrointestinal neoplasmshead /neck neoplasmhealth services research taghormone therapyhuman subjecthuman therapy evaluationinhalation drug administrationinterferonsinterleukin 2lung neoplasmsmedical outreach /case findingmedical rehabilitation related tagmelanomaneoplasm /cancer chemotherapyneoplasm /cancer educationneoplasm /cancer geneticsneoplasm /cancer immunotherapyneoplasm /cancer palliative treatmentneoplasm /cancer radiation therapyneoplasm /cancer surgeryneoplasm /cancer therapypancreas neoplasmspatient oriented researchprostate neoplasmsseleniumtocopherolstopical drug application
项目摘要
DESCRIPTION (provided by applicant): The Missouri Valley Cancer Consortium
(MVCC) is a community-based research effort with the specific aim of providing
quality cancer care and research opportunities to patients in their respective
communities. This is accomplished primarily through a networking of
physicians, hospitals, and community cancer clinics across Nebraska and Iowa
who recognize the unique needs of people with cancer, and who are committed to
providing cancer care that has an emphasis on research whereby patients may
benefit from cutting-edge technology in the areas of cancer treatment, cancer
control, and cancer prevention. The MVCC serves a catchment area of primarily
Nebraska and Iowa, and through affiliation with nationally recognized research
groups, clinical trials are offered for a wide variety of cancers. A unique
ability to provide clinical trials for cancer prevention and cancer control
enhances the quality of this vital research program. The MVCC has direct
affiliation with the North Central Cancer Treatment Group, Eastern Cooperative
Oncology Group, Radiation Therapy Oncology Group, National Surgical Adjuvant
Breast and Bowel Project, Gynecologic Oncology Group, and Southwest Oncology
Group, is a member of the CTSU, or Clinical Trials Support Unit of the NIH,
receives funding to support the program through an NIH grant as a Community
Clinical Oncology Program (CCOP), and serves a data base of well over 1800
patients who have enrolled in clinical research studies over the years through
their own community medical programs affiliated with MVCC. The MVCC has a
proven track record of producing quality research work from a deeply committed
team of healthcare professionals. Efforts are now being focused on community
awareness of the importance of clinical research participation through
pathways of public education about cancer, along with cancer screening and
cancer prevention programs. Strategies to include minority populations in
these important programs are being utilized as well. The long-term objective
of this vital research program is to provide cancer patients access to
clinical trials in their community, to promote quality cancer care and
education, and to produce research data that will ultimately benefit all
cancer patients.
描述(由申请人提供):密苏里谷癌症联盟
(MVCC)是一项基于社区的研究工作,其特定目的是提供
优质的癌症护理和研究机会
社区。这主要通过
内布拉斯加州和爱荷华州的医师,医院和社区癌症诊所
认识到癌症患者的独特需求,并致力于
提供强调研究的癌症护理
在癌症治疗领域,癌症领域的尖端技术受益
控制和预防癌症。 MVCC为集水区提供主要
内布拉斯加州和爱荷华州,并通过与全国认可的研究联系
小组,为各种癌症提供临床试验。一个独特的
能够为预防癌症和癌症控制提供临床试验
提高了这个重要的研究计划的质量。 MVCC有直接
与北中央癌症治疗小组的隶属关系东部合作社
肿瘤学组,放射疗法肿瘤学小组,国家手术辅助组织
乳房和肠道项目,妇科肿瘤学组和西南肿瘤学
Group是CTSU的成员,或NIH的临床试验支持单位
获得资金以通过NIH赠款作为社区支持该计划
临床肿瘤学计划(CCOP),并提供1800多个数据库
多年来一直在参加临床研究的患者
他们自己的社区医疗计划隶属于MVCC。 MVCC有一个
从坚定的致力于
医疗保健专业人员团队。现在努力专注于社区
意识到临床研究参与的重要性
关于癌症的公共教育途径,以及癌症筛查和
预防癌症计划。将少数族裔包括在内的策略
这些重要的程序也正在使用。长期目标
这个重要的研究计划是为癌症患者提供进入
社区中的临床试验,以促进优质的癌症护理和
教育,并产生最终使所有人受益的研究数据
癌症患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gamini Soori其他文献
Gamini Soori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gamini Soori', 18)}}的其他基金
相似国自然基金
具有协同药效的金配合物前药分子设计、可控性活化和抗肿瘤活性研究
- 批准号:22377154
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
“减毒增效”—一类新型核苷类抗肿瘤前药的发现与生物学研究
- 批准号:82304303
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
荷载鞭毛蛋白的载药囊泡激发中性粒细胞抗肿瘤效应及其机制研究
- 批准号:82303724
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
光笼型Mcl-1抑制剂前药的构建与光活化靶向抗肿瘤作用研究
- 批准号:82304305
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
溶酶体靶向聚集性无药抗肿瘤纳米颗粒的研究
- 批准号:52303170
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
St. Vincent Hospital Regional Cancer Center CCOP
圣文森特医院地区癌症中心 CCOP
- 批准号:
7082876 - 财政年份:2002
- 资助金额:
$ 93.6万 - 项目类别:
St. Vincent Hospital Regional Cancer Center CCOP
圣文森特医院地区癌症中心 CCOP
- 批准号:
6754422 - 财政年份:2002
- 资助金额:
$ 93.6万 - 项目类别:
St. Vincent Hospital Regional Cancer Center CCOP
圣文森特医院地区癌症中心 CCOP
- 批准号:
6642810 - 财政年份:2002
- 资助金额:
$ 93.6万 - 项目类别:
St. Vincent Hospital Regional Cancer Center CCOP
圣文森特医院地区癌症中心 CCOP
- 批准号:
6924324 - 财政年份:2002
- 资助金额:
$ 93.6万 - 项目类别:
St. Vincent Hospital Regional Cancer Center CCOP
圣文森特医院地区癌症中心 CCOP
- 批准号:
6479890 - 财政年份:2002
- 资助金额:
$ 93.6万 - 项目类别: